Pulmonary delivery of drugs for bone disorders
- 17 August 2000
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 42 (3) , 239-248
- https://doi.org/10.1016/s0169-409x(00)00064-8
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Safety of Inhaled Proteins for Therapeutic UseJournal of Aerosol Medicine, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosisPublished by Elsevier ,1997
- Efficacy and safety of drugs for Paget's disease of boneBone, 1995
- Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year studyClinical Therapeutics, 1995
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Effect of inhaled natural interferon-alpha on diffuse bronchioalveolar carcinomaEuropean Journal of Cancer and Clinical Oncology, 1990
- Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.Journal of Clinical Investigation, 1981
- ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1976
- Calcitonin Receptors of Kidney and BoneScience, 1972